• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FBXO22通过WNT/β-连环蛋白信号通路调节食管癌细胞的增殖、迁移和侵袭。

FBXO22 regulates proliferation, migration, and invasion of esophageal cancer cells via the WNT/β-catenin signaling pathway.

作者信息

Zheng Rui, Xu Wangwang, Ma Li, Wang Jing, Ma Jia, Liu Chen, Yu Li, Li Yuyun, Zhang Yingjie, Xu Hui

机构信息

Bengbu Medical College Key Laboratory of Cancer Research and Clinical Laboratory Diagnosis, Bengbu Medical University Bengbu 233030, Anhui, China.

Department of Clinical Laboratory, The 901th Hospital of The Joint Logistics Support Force of The People's Liberation Army Hefei 230031, Anhui, China.

出版信息

Am J Transl Res. 2025 Aug 15;17(8):5962-5974. doi: 10.62347/TOAI4814. eCollection 2025.

DOI:10.62347/TOAI4814
PMID:40950282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12432743/
Abstract

OBJECTIVES

FBXO22, a member of the F-box family, plays a crucial role in cancer development and progression. However, its expression and biological functions in esophageal cancer (ESCA) remain poorly understood.

METHODS

In this study, we investigated FBXO22 expression in ESCA cancer tissues using immunohistochemistry and Western blot analyses. Functional assays, including CCK-8, flow cytometry, Western blot, scratch healing, and Transwell migration and invasion assays, were employed to evaluate the effects of FBXO22 modulation on ESCA cell viability, apoptosis, migration, and invasion. Additionally, a nude mouse model was used to assess the impact of FBXO22 silencing on tumor growth.

RESULTS

We found that FBXO22 expression was upregulated in ESCA tissues compared to normal tissues. Silencing FBXO22 inhibited ESCA cell viability, migration and invasion while promoting apoptosis. Conversely, FBXO22 overexpression had the opposite effects. Mechanistically, FBXO22 was found to influence the WNT/β-catenin signaling pathway, and its silencing retarded tumor growth in vivo.

CONCLUSIONS

Our findings highlight the critical role of FBXO22 in ESCA progression and suggest it as a potential therapeutic target for ESCA.

摘要

目的

F-box家族成员FBXO22在癌症发生发展中起关键作用。然而,其在食管癌(ESCA)中的表达及生物学功能仍知之甚少。

方法

在本研究中,我们采用免疫组织化学和蛋白质印迹分析方法,研究FBXO22在ESCA癌组织中的表达情况。运用包括CCK-8、流式细胞术、蛋白质印迹、划痕愈合以及Transwell迁移和侵袭实验等功能实验,评估FBXO22调控对ESCA细胞活力、凋亡、迁移和侵袭的影响。此外,利用裸鼠模型评估FBXO22沉默对肿瘤生长的影响。

结果

我们发现,与正常组织相比,FBXO22在ESCA组织中的表达上调。沉默FBXO22可抑制ESCA细胞活力、迁移和侵袭,同时促进细胞凋亡。相反,FBXO22过表达则产生相反的效果。机制上,发现FBXO22影响WNT/β-连环蛋白信号通路,其沉默可抑制体内肿瘤生长。

结论

我们的研究结果突出了FBXO22在ESCA进展中的关键作用,并表明它是ESCA的一个潜在治疗靶点。

相似文献

1
FBXO22 regulates proliferation, migration, and invasion of esophageal cancer cells via the WNT/β-catenin signaling pathway.FBXO22通过WNT/β-连环蛋白信号通路调节食管癌细胞的增殖、迁移和侵袭。
Am J Transl Res. 2025 Aug 15;17(8):5962-5974. doi: 10.62347/TOAI4814. eCollection 2025.
2
Silencing of PIGU inhibits the progression of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway.PIGU基因沉默通过PI3K/AKT信号通路抑制食管鳞状细胞癌的进展。
Sci Rep. 2025 Aug 25;15(1):31237. doi: 10.1038/s41598-025-08748-y.
3
USP14 inhibition by degrasyn induces YAP1 degradation and suppresses the progression of radioresistant esophageal cancer.德格拉辛对USP14的抑制作用可诱导YAP1降解并抑制耐放射性食管癌的进展。
Neoplasia. 2025 Feb;60:101101. doi: 10.1016/j.neo.2024.101101. Epub 2024 Dec 14.
4
TROAP regulates cell cycle and promotes tumor progression through Wnt/β-Catenin signaling pathway in glioma cells.TROAP通过胶质瘤细胞中的Wnt/β-连环蛋白信号通路调节细胞周期并促进肿瘤进展。
CNS Neurosci Ther. 2021 Jun 2;27(9):1064-76. doi: 10.1111/cns.13688.
5
Mechanistic study on the inhibition of triple-negative breast cancer progression by LncRNA TFAP2A-AS1 through the regulation of miR-6892/PHGDH.LncRNA TFAP2A-AS1通过调控miR-6892/PHGDH抑制三阴性乳腺癌进展的机制研究
Inflamm Res. 2025 Sep 10;74(1):121. doi: 10.1007/s00011-025-02092-7.
6
SNRPB2 facilitates esophageal squamous cell carcinoma oncogenesis and progression via E2F4 stabilization.SNRPB2通过稳定E2F4促进食管鳞状细胞癌的发生和发展。
Front Immunol. 2025 Jun 19;16:1610721. doi: 10.3389/fimmu.2025.1610721. eCollection 2025.
7
CST2 promotes cell proliferation and regulates cell cycle by activating Wnt-β-catenin signalling pathway in serous ovarian cancer.CST2 通过激活浆液性卵巢癌细胞中的 Wnt-β-连环蛋白信号通路促进细胞增殖并调节细胞周期。
J Obstet Gynaecol. 2024 Dec;44(1):2363515. doi: 10.1080/01443615.2024.2363515. Epub 2024 Jun 12.
8
Expression of WNT10A in papillary thyroid carcinoma and its effect on cell proliferation, invasion, and metastasis.WNT10A在甲状腺乳头状癌中的表达及其对细胞增殖、侵袭和转移的影响。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 28;50(3):402-415. doi: 10.11817/j.issn.1672-7347.2025.240237.
9
Hsa_circ_0002238 promotes the malignant behavior of colorectal cancer.人源环状RNA hsa_circ_0002238促进结直肠癌的恶性行为。
Front Pharmacol. 2025 Jun 13;16:1541820. doi: 10.3389/fphar.2025.1541820. eCollection 2025.
10
TMEM196 inhibits lung cancer metastasis by regulating the Wnt/β-catenin signaling pathway.TMEM196 通过调控 Wnt/β-catenin 信号通路抑制肺癌转移。
J Cancer Res Clin Oncol. 2023 Feb;149(2):653-667. doi: 10.1007/s00432-022-04363-w. Epub 2022 Nov 10.

本文引用的文献

1
Wnt/β-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy.Wnt/β-连环蛋白介导的癌症信号通路:最新进展及其在癌症治疗中的应用
Mol Cancer. 2025 Jun 10;24(1):171. doi: 10.1186/s12943-025-02363-1.
2
Impact of targeting the platelet-activating factor and its receptor in cancer treatment.靶向血小板活化因子及其受体在癌症治疗中的作用
Mil Med Res. 2025 Mar 4;12(1):10. doi: 10.1186/s40779-025-00597-0.
3
Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases.解决外泌体和核受体相互作用:慢性疾病治疗的新兴范例。
Mil Med Res. 2024 Sep 26;11(1):67. doi: 10.1186/s40779-024-00564-1.
4
Advances in diagnosis and management of cancer of the esophagus.食管癌的诊断与治疗进展。
BMJ. 2024 Jun 3;385:e074962. doi: 10.1136/bmj-2023-074962.
5
p53/MDM2 signaling pathway in aging, senescence and tumorigenesis.p53/MDM2 信号通路在衰老、衰老和肿瘤发生中的作用。
Semin Cancer Biol. 2024 Jun;101:44-57. doi: 10.1016/j.semcancer.2024.05.001. Epub 2024 May 17.
6
Deciphering the molecular interplay and tumorigenesis in hepatocellular carcinoma through insights into FBXL6 and KRAS.通过深入了解FBXL6和KRAS来解析肝细胞癌中的分子相互作用和肿瘤发生机制。
Mil Med Res. 2024 Feb 8;11(1):9. doi: 10.1186/s40779-024-00515-w.
7
Elevated FBXL6 activates both wild-type KRAS and mutant KRAS and drives HCC tumorigenesis via the ERK/mTOR/PRELID2/ROS axis in mice.FBXL6 升高可激活野生型 KRAS 和突变型 KRAS,并通过 ERK/mTOR/PRELID2/ROS 轴在小鼠中驱动 HCC 肿瘤发生。
Mil Med Res. 2023 Dec 20;10(1):68. doi: 10.1186/s40779-023-00501-8.
8
B-cell lymphoma-2 family proteins in the crosshairs: Small molecule inhibitors and activators for cancer therapy.B 细胞淋巴瘤-2 家族蛋白成为焦点:癌症治疗的小分子抑制剂和激活剂。
Med Res Rev. 2024 Mar;44(2):707-737. doi: 10.1002/med.21999. Epub 2023 Nov 20.
9
FBXO22 inhibits proliferation and metastasis of cervical cancer cells by mediating ubiquitination-dependent degradation of GAK.FBXO22 通过介导 GAK 的泛素化依赖降解来抑制宫颈癌细胞的增殖和转移。
Exp Cell Res. 2023 Sep 1;430(1):113719. doi: 10.1016/j.yexcr.2023.113719. Epub 2023 Jul 12.
10
FBXO22 Mediates the NGF/TRKA Signaling Pathway in Bone Metastases in Prostate Cancer.FBXO22 介导前列腺癌骨转移中的 NGF/TRKA 信号通路。
Am J Pathol. 2023 Sep;193(9):1248-1266. doi: 10.1016/j.ajpath.2023.05.012. Epub 2023 Jun 8.